Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS)

Clinical trial NCT07268222 · RECRUITING

Trial details

NCT number: NCT07268222
Sponsor: Laikο General Hospital, Athens
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Mild Autonomous Cortisol Secretion (MACS)

Start date: 2025-12-01
Primary completion: 2026-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.